Ganglioside-monosialic acid (GM1) for prevention of chemotherapy-induced peripheral neuropathy: a meta-analysis with trial sequential analysis

BACKGROUND: Chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting side effect that largely remains an unresolved clinical issue, leading to long-term morbidity. This meta-analysis aimed to evaluate the efficacy and safety of Ganglioside-monosialic acid (GM1) in preventing CIPN. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Shaoyong, Bai, Xiaohui, Guo, Caixia, Huang, Zhimei, Ouyang, Handong, Huang, Jingxiu, Zeng, Weian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564974/
https://www.ncbi.nlm.nih.gov/pubmed/34727879
http://dx.doi.org/10.1186/s12885-021-08884-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564974/
https://www.ncbi.nlm.nih.gov/pubmed/34727879
http://dx.doi.org/10.1186/s12885-021-08884-4

Ejemplares similares